SCHEMBL6752655

SCHEMBL6752655

O=[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.80

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.80
▸ TDP1 Q9NUW8 1/20 0.80
▸ ESR1 P03372 4/20 0.57
▸ ESR2 Q92731 4/20 0.57
▸ KDM4E B2RXH2 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ ALDH1A1 P00352 4/20 0.35
▸ LMNA P02545 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.34
▸ DRD1 P21728 2/20 0.33
▸ CA4 P22748 2/20 0.33
▸ CES2 O00748 2/20 0.33
▸ CES1 P23141 2/20 0.33
▸ CA2 P00918 1/20 0.33
▸ DAO P14920 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ NAPRT Q6XQN6 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ HTR6 P50406 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27546796 1.00 CYP3A4 (0.80) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL2387556 0.90 TDP1 (0.86) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL2085135 0.89 TDP1 (1.00) CYP3A4TDP1ESR1ESR2KDM4E
Benzene SCHEMBL6890099 0.89 TDP1 (1.00) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL5028587 0.89 TDP1 (1.00) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL101 0.89 TDP1 (1.00) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL30213620 0.87 TDP1 (0.80) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL6543576 0.87 CYP3A4 (0.80) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL21296015 0.87 TDP1 (0.80) CYP3A4TDP1ESR1ESR2KDM4E
Formaldehyde SCHEMBL28995047 0.87 CYP3A4 (0.80) CYP3A4TDP1ESR1ESR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436429-A2 TARGETED NUCLEIC ACID CONSTRUCTS AND USES RELATED THERETO THE GENERAL HOSPITAL CORPORATION (US) 2004-07-14 — — EP disclosed
US-20030049203-A1 Targeted nucleic acid constructs and uses related thereto ENERGY, UNITED STATES DEPARTMENT OF 2003-03-13 — — US disclosed
WO-2003020949-A2 TARGETED NUCLEIC ACID CONSTRUCTS AND USES RELATED THERETO THE GENERAL HOSPITAL CORPORATION (US) 2003-03-13 — — WO disclosed
Send feedback